Safety and Tolerability of a Modified Ublituximab Dosing Regimen: Updates from the ENHANCE Study By Sheena Cruz / 04/21/2026
Safety and Tolerability of a Modified Ublituximab Dosing Regimen: Updates from the ENHANCE Study By admin / 09/24/2025
Evaluating the Maintenance of Efficacy and Tolerability of Transitioning from IV Anti-CD20 Therapy to Ublituximab: ENHANCE Study Interim Data By admin / 02/29/2024
